CIK 0001873875 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Incannex Healthcare Inc.
Sign in to watch- Ticker
- IXHL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- Phone
- 61 409 840 786
- Business address
- 8 CENTURY CIRCUIT, STE. 105, NORWEST NSW, Australia
- Former names
- Incannex Healthcare Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-14 | Valentine Troy Director | Grant or award | +11,302,608 | 12,001,858 | ||
| 2025-11-14 | Clark Robert Director | Grant or award | +1,686,956 | 1,786,956 | ||
| 2025-11-14 | Widdows Peter Director | Grant or award | +1,686,956 | 1,957,803 | ||
| 2025-11-14 | Swan Joseph CFO, Treasurer and Secretary | Grant or award | +869,565 | 921,358 | ||
| 2025-11-14 | Latham Joel CEO and President | Grant or award | +22,608,692 | 24,186,177 | ||
| 2025-11-14 | Anastassov George Director | Grant or award | +1,686,956 | 2,456,677 | ||
| 2024-10-23 | Barbato Luigi M. Chief Medical Officer | Grant or award | +100,476 | 100,476 | ||
| 2023-12-21 | Valentine Troy Director | Grant or award | +670,000 | 699,250 | ||
| 2023-12-21 | Widdows Peter Director | Grant or award | +100,000 | 270,847 | ||
| 2023-12-21 | Latham Joel CEO and President | Grant or award | +1,340,000 | 1,577,485 | ||
| 2023-12-21 | Anastassov George Director | Grant or award | +100,000 | 769,721 | ||
| 2023-12-21 | Clark Robert Director | Grant or award | +100,000 | 100,000 |
Page 1 of 1 · 12 trades